Global Prescription Weight Loss Pills Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Prescription Weight Loss Pills market size was valued at USD 1162.7 million in 2022 and is forecast to a readjusted size of USD 2259 million by 2029 with a CAGR of 10.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
This report is a detailed and comprehensive analysis for global Prescription Weight Loss Pills market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Weight Loss Pills market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Weight Loss Pills
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Weight Loss Pills market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree) and Eli Lilly and Company (TRICARE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Prescription Weight Loss Pills market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Prescription Weight Loss Pills product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prescription Weight Loss Pills, with price, sales, revenue and global market share of Prescription Weight Loss Pills from 2018 to 2023.
Chapter 3, the Prescription Weight Loss Pills competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Weight Loss Pills breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prescription Weight Loss Pills market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prescription Weight Loss Pills.
Chapter 14 and 15, to describe Prescription Weight Loss Pills sales channel, distributors, customers, research findings and conclusion.
Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.
This report is a detailed and comprehensive analysis for global Prescription Weight Loss Pills market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Weight Loss Pills market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prescription Weight Loss Pills market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Weight Loss Pills
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Weight Loss Pills market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree) and Eli Lilly and Company (TRICARE), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Prescription Weight Loss Pills market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral Tablets
- Oral Capsules
- Injections
- Hospital
- Pharmacy
- Currax Pharmaceuticals (Contrave)
- VIVUS (Qsymia)
- Novo Nordisk A/S
- Rhythm Pharmaceuticals (Imcivree)
- Eli Lilly and Company (TRICARE)
- CHEPLAPHARM (Xenical)
- Pfizer
- Teva Pharmaceutical (Actavis)
- Haleon Group (alli)
- Sanofi (Adlyxin)
- AstraZeneca (BYDUREON BCise)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Prescription Weight Loss Pills product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prescription Weight Loss Pills, with price, sales, revenue and global market share of Prescription Weight Loss Pills from 2018 to 2023.
Chapter 3, the Prescription Weight Loss Pills competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Weight Loss Pills breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prescription Weight Loss Pills market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prescription Weight Loss Pills.
Chapter 14 and 15, to describe Prescription Weight Loss Pills sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Prescription Weight Loss Pills
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Tablets
1.3.3 Oral Capsules
1.3.4 Injections
1.4 Market Analysis by Application
1.4.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Prescription Weight Loss Pills Market Size & Forecast
1.5.1 Global Prescription Weight Loss Pills Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prescription Weight Loss Pills Sales Quantity (2018-2029)
1.5.3 Global Prescription Weight Loss Pills Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Currax Pharmaceuticals (Contrave)
2.1.1 Currax Pharmaceuticals (Contrave) Details
2.1.2 Currax Pharmaceuticals (Contrave) Major Business
2.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
2.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
2.2 VIVUS (Qsymia)
2.2.1 VIVUS (Qsymia) Details
2.2.2 VIVUS (Qsymia) Major Business
2.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
2.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 VIVUS (Qsymia) Recent Developments/Updates
2.3 Novo Nordisk A/S
2.3.1 Novo Nordisk A/S Details
2.3.2 Novo Nordisk A/S Major Business
2.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
2.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk A/S Recent Developments/Updates
2.4 Rhythm Pharmaceuticals (Imcivree)
2.4.1 Rhythm Pharmaceuticals (Imcivree) Details
2.4.2 Rhythm Pharmaceuticals (Imcivree) Major Business
2.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
2.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
2.5 Eli Lilly and Company (TRICARE)
2.5.1 Eli Lilly and Company (TRICARE) Details
2.5.2 Eli Lilly and Company (TRICARE) Major Business
2.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
2.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
2.6 CHEPLAPHARM (Xenical)
2.6.1 CHEPLAPHARM (Xenical) Details
2.6.2 CHEPLAPHARM (Xenical) Major Business
2.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
2.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Prescription Weight Loss Pills Product and Services
2.7.4 Pfizer Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical (Actavis)
2.8.1 Teva Pharmaceutical (Actavis) Details
2.8.2 Teva Pharmaceutical (Actavis) Major Business
2.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
2.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
2.9 Haleon Group (alli)
2.9.1 Haleon Group (alli) Details
2.9.2 Haleon Group (alli) Major Business
2.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product and Services
2.9.4 Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Haleon Group (alli) Recent Developments/Updates
2.10 Sanofi (Adlyxin)
2.10.1 Sanofi (Adlyxin) Details
2.10.2 Sanofi (Adlyxin) Major Business
2.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
2.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi (Adlyxin) Recent Developments/Updates
2.11 AstraZeneca (BYDUREON BCise)
2.11.1 AstraZeneca (BYDUREON BCise) Details
2.11.2 AstraZeneca (BYDUREON BCise) Major Business
2.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
2.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRESCRIPTION WEIGHT LOSS PILLS BY MANUFACTURER
3.1 Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023)
3.3 Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prescription Weight Loss Pills by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.4.2 Top 6 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.5 Prescription Weight Loss Pills Market: Overall Company Footprint Analysis
3.5.1 Prescription Weight Loss Pills Market: Region Footprint
3.5.2 Prescription Weight Loss Pills Market: Company Product Type Footprint
3.5.3 Prescription Weight Loss Pills Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prescription Weight Loss Pills Market Size by Region
4.1.1 Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
4.1.2 Global Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
4.1.3 Global Prescription Weight Loss Pills Average Price by Region (2018-2029)
4.2 North America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.3 Europe Prescription Weight Loss Pills Consumption Value (2018-2029)
4.4 Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029)
4.5 South America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.6 Middle East and Africa Prescription Weight Loss Pills Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
5.2 Global Prescription Weight Loss Pills Consumption Value by Type (2018-2029)
5.3 Global Prescription Weight Loss Pills Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
6.2 Global Prescription Weight Loss Pills Consumption Value by Application (2018-2029)
6.3 Global Prescription Weight Loss Pills Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
7.2 North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
7.3 North America Prescription Weight Loss Pills Market Size by Country
7.3.1 North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
7.3.2 North America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
8.2 Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
8.3 Europe Prescription Weight Loss Pills Market Size by Country
8.3.1 Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
8.3.2 Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prescription Weight Loss Pills Market Size by Region
9.3.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
10.2 South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
10.3 South America Prescription Weight Loss Pills Market Size by Country
10.3.1 South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
10.3.2 South America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prescription Weight Loss Pills Market Size by Country
11.3.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Prescription Weight Loss Pills Market Drivers
12.2 Prescription Weight Loss Pills Market Restraints
12.3 Prescription Weight Loss Pills Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prescription Weight Loss Pills and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prescription Weight Loss Pills
13.3 Prescription Weight Loss Pills Production Process
13.4 Prescription Weight Loss Pills Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prescription Weight Loss Pills Typical Distributors
14.3 Prescription Weight Loss Pills Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Prescription Weight Loss Pills
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Tablets
1.3.3 Oral Capsules
1.3.4 Injections
1.4 Market Analysis by Application
1.4.1 Overview: Global Prescription Weight Loss Pills Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Prescription Weight Loss Pills Market Size & Forecast
1.5.1 Global Prescription Weight Loss Pills Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prescription Weight Loss Pills Sales Quantity (2018-2029)
1.5.3 Global Prescription Weight Loss Pills Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Currax Pharmaceuticals (Contrave)
2.1.1 Currax Pharmaceuticals (Contrave) Details
2.1.2 Currax Pharmaceuticals (Contrave) Major Business
2.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
2.1.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Currax Pharmaceuticals (Contrave) Recent Developments/Updates
2.2 VIVUS (Qsymia)
2.2.1 VIVUS (Qsymia) Details
2.2.2 VIVUS (Qsymia) Major Business
2.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
2.2.4 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 VIVUS (Qsymia) Recent Developments/Updates
2.3 Novo Nordisk A/S
2.3.1 Novo Nordisk A/S Details
2.3.2 Novo Nordisk A/S Major Business
2.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
2.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk A/S Recent Developments/Updates
2.4 Rhythm Pharmaceuticals (Imcivree)
2.4.1 Rhythm Pharmaceuticals (Imcivree) Details
2.4.2 Rhythm Pharmaceuticals (Imcivree) Major Business
2.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
2.4.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
2.5 Eli Lilly and Company (TRICARE)
2.5.1 Eli Lilly and Company (TRICARE) Details
2.5.2 Eli Lilly and Company (TRICARE) Major Business
2.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
2.5.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company (TRICARE) Recent Developments/Updates
2.6 CHEPLAPHARM (Xenical)
2.6.1 CHEPLAPHARM (Xenical) Details
2.6.2 CHEPLAPHARM (Xenical) Major Business
2.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
2.6.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CHEPLAPHARM (Xenical) Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Prescription Weight Loss Pills Product and Services
2.7.4 Pfizer Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Teva Pharmaceutical (Actavis)
2.8.1 Teva Pharmaceutical (Actavis) Details
2.8.2 Teva Pharmaceutical (Actavis) Major Business
2.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
2.8.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Teva Pharmaceutical (Actavis) Recent Developments/Updates
2.9 Haleon Group (alli)
2.9.1 Haleon Group (alli) Details
2.9.2 Haleon Group (alli) Major Business
2.9.3 Haleon Group (alli) Prescription Weight Loss Pills Product and Services
2.9.4 Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Haleon Group (alli) Recent Developments/Updates
2.10 Sanofi (Adlyxin)
2.10.1 Sanofi (Adlyxin) Details
2.10.2 Sanofi (Adlyxin) Major Business
2.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
2.10.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi (Adlyxin) Recent Developments/Updates
2.11 AstraZeneca (BYDUREON BCise)
2.11.1 AstraZeneca (BYDUREON BCise) Details
2.11.2 AstraZeneca (BYDUREON BCise) Major Business
2.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
2.11.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AstraZeneca (BYDUREON BCise) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRESCRIPTION WEIGHT LOSS PILLS BY MANUFACTURER
3.1 Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023)
3.3 Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prescription Weight Loss Pills by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.4.2 Top 6 Prescription Weight Loss Pills Manufacturer Market Share in 2022
3.5 Prescription Weight Loss Pills Market: Overall Company Footprint Analysis
3.5.1 Prescription Weight Loss Pills Market: Region Footprint
3.5.2 Prescription Weight Loss Pills Market: Company Product Type Footprint
3.5.3 Prescription Weight Loss Pills Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prescription Weight Loss Pills Market Size by Region
4.1.1 Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
4.1.2 Global Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
4.1.3 Global Prescription Weight Loss Pills Average Price by Region (2018-2029)
4.2 North America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.3 Europe Prescription Weight Loss Pills Consumption Value (2018-2029)
4.4 Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029)
4.5 South America Prescription Weight Loss Pills Consumption Value (2018-2029)
4.6 Middle East and Africa Prescription Weight Loss Pills Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
5.2 Global Prescription Weight Loss Pills Consumption Value by Type (2018-2029)
5.3 Global Prescription Weight Loss Pills Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
6.2 Global Prescription Weight Loss Pills Consumption Value by Application (2018-2029)
6.3 Global Prescription Weight Loss Pills Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
7.2 North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
7.3 North America Prescription Weight Loss Pills Market Size by Country
7.3.1 North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
7.3.2 North America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
8.2 Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
8.3 Europe Prescription Weight Loss Pills Market Size by Country
8.3.1 Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
8.3.2 Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prescription Weight Loss Pills Market Size by Region
9.3.1 Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
10.2 South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
10.3 South America Prescription Weight Loss Pills Market Size by Country
10.3.1 South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
10.3.2 South America Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prescription Weight Loss Pills Market Size by Country
11.3.1 Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prescription Weight Loss Pills Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Prescription Weight Loss Pills Market Drivers
12.2 Prescription Weight Loss Pills Market Restraints
12.3 Prescription Weight Loss Pills Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prescription Weight Loss Pills and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prescription Weight Loss Pills
13.3 Prescription Weight Loss Pills Production Process
13.4 Prescription Weight Loss Pills Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prescription Weight Loss Pills Typical Distributors
14.3 Prescription Weight Loss Pills Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Currax Pharmaceuticals (Contrave) Basic Information, Manufacturing Base and Competitors
Table 4. Currax Pharmaceuticals (Contrave) Major Business
Table 5. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
Table 6. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
Table 8. VIVUS (Qsymia) Basic Information, Manufacturing Base and Competitors
Table 9. VIVUS (Qsymia) Major Business
Table 10. VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
Table 11. VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. VIVUS (Qsymia) Recent Developments/Updates
Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk A/S Major Business
Table 15. Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
Table 16. Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novo Nordisk A/S Recent Developments/Updates
Table 18. Rhythm Pharmaceuticals (Imcivree) Basic Information, Manufacturing Base and Competitors
Table 19. Rhythm Pharmaceuticals (Imcivree) Major Business
Table 20. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
Table 21. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
Table 23. Eli Lilly and Company (TRICARE) Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company (TRICARE) Major Business
Table 25. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
Table 26. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company (TRICARE) Recent Developments/Updates
Table 28. CHEPLAPHARM (Xenical) Basic Information, Manufacturing Base and Competitors
Table 29. CHEPLAPHARM (Xenical) Major Business
Table 30. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
Table 31. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CHEPLAPHARM (Xenical) Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Prescription Weight Loss Pills Product and Services
Table 36. Pfizer Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Teva Pharmaceutical (Actavis) Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical (Actavis) Major Business
Table 40. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
Table 41. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical (Actavis) Recent Developments/Updates
Table 43. Haleon Group (alli) Basic Information, Manufacturing Base and Competitors
Table 44. Haleon Group (alli) Major Business
Table 45. Haleon Group (alli) Prescription Weight Loss Pills Product and Services
Table 46. Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Haleon Group (alli) Recent Developments/Updates
Table 48. Sanofi (Adlyxin) Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi (Adlyxin) Major Business
Table 50. Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
Table 51. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanofi (Adlyxin) Recent Developments/Updates
Table 53. AstraZeneca (BYDUREON BCise) Basic Information, Manufacturing Base and Competitors
Table 54. AstraZeneca (BYDUREON BCise) Major Business
Table 55. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
Table 56. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
Table 58. Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Prescription Weight Loss Pills, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Prescription Weight Loss Pills Production Site of Key Manufacturer
Table 63. Prescription Weight Loss Pills Market: Company Product Type Footprint
Table 64. Prescription Weight Loss Pills Market: Company Product Application Footprint
Table 65. Prescription Weight Loss Pills New Market Entrants and Barriers to Market Entry
Table 66. Prescription Weight Loss Pills Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Prescription Weight Loss Pills Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Prescription Weight Loss Pills Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Prescription Weight Loss Pills Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Prescription Weight Loss Pills Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Prescription Weight Loss Pills Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Prescription Weight Loss Pills Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Prescription Weight Loss Pills Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Prescription Weight Loss Pills Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Prescription Weight Loss Pills Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Prescription Weight Loss Pills Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Prescription Weight Loss Pills Raw Material
Table 126. Key Manufacturers of Prescription Weight Loss Pills Raw Materials
Table 127. Prescription Weight Loss Pills Typical Distributors
Table 128. Prescription Weight Loss Pills Typical Customers
Table 1. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Currax Pharmaceuticals (Contrave) Basic Information, Manufacturing Base and Competitors
Table 4. Currax Pharmaceuticals (Contrave) Major Business
Table 5. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product and Services
Table 6. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Currax Pharmaceuticals (Contrave) Recent Developments/Updates
Table 8. VIVUS (Qsymia) Basic Information, Manufacturing Base and Competitors
Table 9. VIVUS (Qsymia) Major Business
Table 10. VIVUS (Qsymia) Prescription Weight Loss Pills Product and Services
Table 11. VIVUS (Qsymia) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. VIVUS (Qsymia) Recent Developments/Updates
Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk A/S Major Business
Table 15. Novo Nordisk A/S Prescription Weight Loss Pills Product and Services
Table 16. Novo Nordisk A/S Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novo Nordisk A/S Recent Developments/Updates
Table 18. Rhythm Pharmaceuticals (Imcivree) Basic Information, Manufacturing Base and Competitors
Table 19. Rhythm Pharmaceuticals (Imcivree) Major Business
Table 20. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product and Services
Table 21. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Rhythm Pharmaceuticals (Imcivree) Recent Developments/Updates
Table 23. Eli Lilly and Company (TRICARE) Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company (TRICARE) Major Business
Table 25. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product and Services
Table 26. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company (TRICARE) Recent Developments/Updates
Table 28. CHEPLAPHARM (Xenical) Basic Information, Manufacturing Base and Competitors
Table 29. CHEPLAPHARM (Xenical) Major Business
Table 30. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product and Services
Table 31. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CHEPLAPHARM (Xenical) Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Prescription Weight Loss Pills Product and Services
Table 36. Pfizer Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Teva Pharmaceutical (Actavis) Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical (Actavis) Major Business
Table 40. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product and Services
Table 41. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Teva Pharmaceutical (Actavis) Recent Developments/Updates
Table 43. Haleon Group (alli) Basic Information, Manufacturing Base and Competitors
Table 44. Haleon Group (alli) Major Business
Table 45. Haleon Group (alli) Prescription Weight Loss Pills Product and Services
Table 46. Haleon Group (alli) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Haleon Group (alli) Recent Developments/Updates
Table 48. Sanofi (Adlyxin) Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi (Adlyxin) Major Business
Table 50. Sanofi (Adlyxin) Prescription Weight Loss Pills Product and Services
Table 51. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanofi (Adlyxin) Recent Developments/Updates
Table 53. AstraZeneca (BYDUREON BCise) Basic Information, Manufacturing Base and Competitors
Table 54. AstraZeneca (BYDUREON BCise) Major Business
Table 55. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product and Services
Table 56. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. AstraZeneca (BYDUREON BCise) Recent Developments/Updates
Table 58. Global Prescription Weight Loss Pills Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Prescription Weight Loss Pills Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Prescription Weight Loss Pills Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Prescription Weight Loss Pills, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Prescription Weight Loss Pills Production Site of Key Manufacturer
Table 63. Prescription Weight Loss Pills Market: Company Product Type Footprint
Table 64. Prescription Weight Loss Pills Market: Company Product Application Footprint
Table 65. Prescription Weight Loss Pills New Market Entrants and Barriers to Market Entry
Table 66. Prescription Weight Loss Pills Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Prescription Weight Loss Pills Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Prescription Weight Loss Pills Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Prescription Weight Loss Pills Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Prescription Weight Loss Pills Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Prescription Weight Loss Pills Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Prescription Weight Loss Pills Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Prescription Weight Loss Pills Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Prescription Weight Loss Pills Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Prescription Weight Loss Pills Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Prescription Weight Loss Pills Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Prescription Weight Loss Pills Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Prescription Weight Loss Pills Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Prescription Weight Loss Pills Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Prescription Weight Loss Pills Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Prescription Weight Loss Pills Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Prescription Weight Loss Pills Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Prescription Weight Loss Pills Raw Material
Table 126. Key Manufacturers of Prescription Weight Loss Pills Raw Materials
Table 127. Prescription Weight Loss Pills Typical Distributors
Table 128. Prescription Weight Loss Pills Typical Customers
LIST OF FIGURES
Figure 1. Prescription Weight Loss Pills Picture
Figure 2. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prescription Weight Loss Pills Consumption Value Market Share by Type in 2022
Figure 4. Oral Tablets Examples
Figure 5. Oral Capsules Examples
Figure 6. Injections Examples
Figure 7. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Prescription Weight Loss Pills Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Prescription Weight Loss Pills Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Prescription Weight Loss Pills Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Prescription Weight Loss Pills Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Prescription Weight Loss Pills Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Prescription Weight Loss Pills Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Prescription Weight Loss Pills Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Prescription Weight Loss Pills by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Prescription Weight Loss Pills Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Prescription Weight Loss Pills Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Prescription Weight Loss Pills Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Prescription Weight Loss Pills Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 53. China Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Prescription Weight Loss Pills Market Drivers
Figure 74. Prescription Weight Loss Pills Market Restraints
Figure 75. Prescription Weight Loss Pills Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills in 2022
Figure 78. Manufacturing Process Analysis of Prescription Weight Loss Pills
Figure 79. Prescription Weight Loss Pills Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Prescription Weight Loss Pills Picture
Figure 2. Global Prescription Weight Loss Pills Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prescription Weight Loss Pills Consumption Value Market Share by Type in 2022
Figure 4. Oral Tablets Examples
Figure 5. Oral Capsules Examples
Figure 6. Injections Examples
Figure 7. Global Prescription Weight Loss Pills Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Prescription Weight Loss Pills Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Prescription Weight Loss Pills Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Prescription Weight Loss Pills Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Prescription Weight Loss Pills Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Prescription Weight Loss Pills Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Prescription Weight Loss Pills Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Prescription Weight Loss Pills Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Prescription Weight Loss Pills by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Prescription Weight Loss Pills Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Prescription Weight Loss Pills Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Prescription Weight Loss Pills Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Prescription Weight Loss Pills Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Prescription Weight Loss Pills Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Prescription Weight Loss Pills Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 53. China Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Prescription Weight Loss Pills Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Prescription Weight Loss Pills Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Prescription Weight Loss Pills Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Prescription Weight Loss Pills Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Prescription Weight Loss Pills Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Prescription Weight Loss Pills Market Drivers
Figure 74. Prescription Weight Loss Pills Market Restraints
Figure 75. Prescription Weight Loss Pills Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prescription Weight Loss Pills in 2022
Figure 78. Manufacturing Process Analysis of Prescription Weight Loss Pills
Figure 79. Prescription Weight Loss Pills Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
